SAB Biotherapeutics SABS
NASDAQ SABS
$3.03 -0.03 (-1.14%)
As of: Oct 2, 2026 · 10:42 AM EDT

SAB Biotherapeutics (SABS) Shares Outstanding (Diluted) (2020 - 2026)

Updated

SAB Biotherapeutics (SABS) reported Shares Outstanding (Diluted) of 79.75 million for Q2 2026, up 758.1% from 9.29 million a year earlier and up 48.9% from the prior quarter.

Analysis

SAB Biotherapeutics (SABS) Shares Outstanding (Diluted) (2020 - 2026) Analysis & Trends

For FY2025, SAB Biotherapeutics posted Shares Outstanding (Diluted) of 61.34 million, up 562.3% from FY2024.

  • Shares Outstanding (Diluted) has increased for five consecutive years, with a five-year compound annual growth rate of 86.7% (FY2020 to FY2025).
  • By year, Shares Outstanding (Diluted) came in at 9.26 million in FY2024 (+67.7%), 5.52 million in FY2023 (+26.9%), 4.35 million in FY2022 (+59.2%) and 2.73 million in FY2021 (+1.2%).
  • The Q2 2026 figure ranks as the highest quarterly Shares Outstanding (Diluted) in data going back to Q4 2020.
  • Year over year, Shares Outstanding (Diluted) has now increased in each of the last 19 quarters, with growth averaging 335.4% over the last eight quarters.
  • The year-over-year growth in Shares Outstanding (Diluted) has ranged between 0.4% (Q2 2025) and 758.1% (Q2 2026) over the last five years.
  • Per Business Quant data, the three quarters before Q2 2026 came in at 53.56 million (Q1 2026), 61.34 million (Q4 2025) and 77.86 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Dil.) (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 2.44 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 1.77 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.47 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 1.96 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.56 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 544.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 1.24 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 5.70 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 255.20 Mn
10 SAB Biotherapeutics 264.67 Mn 264.67 Mn - 79.75 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 79.75 Mn
Mar 31, 2026 53.56 Mn
Dec 31, 2025 61.34 Mn
Sep 30, 2025 77.86 Mn
Jun 30, 2025 9.29 Mn
Mar 31, 2025 9.29 Mn
Dec 31, 2024 9.26 Mn
Sep 30, 2024 9.26 Mn
Jun 30, 2024 9.26 Mn
Mar 31, 2024 9.24 Mn
Dec 31, 2023 5.52 Mn
Sep 30, 2023 5.24 Mn
Jun 30, 2023 5.04 Mn
Mar 31, 2023 5.04 Mn
Dec 31, 2022 4.35 Mn
Sep 30, 2022 4.30 Mn
Jun 30, 2022 4.30 Mn
Mar 31, 2022 4.58 Mn
Dec 31, 2021 2.73 Mn
Sep 30, 2021 2.60 Mn
API Access

SAB Biotherapeutics Shares Outstanding (Diluted) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=SABS&period=max&api_key=YOUR_API_KEY